Capecitabine plus paclitaxel with sequential capecitabine alone as the firstline therapy in the treatment of recurrent and late gastric cancer.
Phase of Trial: Phase I
Latest Information Update: 22 Apr 2016
At a glance
- Drugs Capecitabine (Primary) ; Paclitaxel
- Indications Gastric cancer
- Focus Therapeutic Use
- 21 May 2012 Planned end date changed from 1 Dec 2007 to 31 Jul 2009 as reported by Chinese Clinical Trial Register.
- 13 Apr 2012 Trial phase changed from II to I as reported by Chinese Clinical Trial Register record.
- 24 Jun 2009 New trial record